$19.36
0.653.47%
Last update: Nov 10, 7:12 AM
Immunome Inc (IMNM) Stock Price, Quote, News & History
IMNMNASDAQ
FDA accepts Immunome's varegacestat NDA for desmoid tumors, with an April 28, 2027, PDUFA date backed by positive Phase 3 data.
You can purchase shares of Immunome (NASDAQ:IMNM) through any online brokerage.
Other companies in Immunome’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Immunome has a consensus price target of $31.53.
The stock price for Immunome (NASDAQ: IMNM) is $19.05 last updated November 10, 2026 at 7:12 AM EST.
There are no upcoming dividends for Immunome.
Immunome does not have any upcoming earnings scheduled.
There is no upcoming split for Immunome.
Immunome is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other...
